Diabetes Distress Scale (DDS17)

Why use it

Diabetes distress is distinct from clinical depression and is a highly prevalent, modifiable condition that directly impacts self-management and glycemic outcomes. The DDS17 identifies patients who may benefit from behavioral health support, diabetes education, or physician communication interventions even when they do not meet criteria for major depressive disorder. It is recommended by the ADA Standards of Medical Care in Diabetes and the ISPAD guidelines for routine assessment in clinical diabetes care.

About

The Diabetes Distress Scale (DDS17) is a validated 17-item self-report questionnaire developed by Polonsky and colleagues to measure the emotional distress specifically related to living with and managing diabetes — a construct distinct from general depression or anxiety. The DDS17 assesses four clinically distinct subscales: (1) Emotional Burden (EB) — distress about the disease itself and living with diabetes; (2) Physician-Related Distress (PD) — concerns about the patient–provider relationship; (3) Regimen-Related Distress (RD) — distress about the demands of the diabetes management regimen; (4) Interpersonal Distress (ID) — distress arising from family or social relationships related to diabetes. Each item is rated on a 6-point Likert scale (1 = Not a problem to 6 = A very serious problem). The total and subscale scores are the mean of respective items. Diabetes distress is common (approximately 18–45% of patients with type 1 or type 2 diabetes) and is independently associated with poor glycemic control, reduced self-care behaviors, and worse quality of life.

When to use

• Routine annual psychosocial screening in all patients with type 1 or type 2 diabetes (per ADA Standards of Care)
• When HbA1c is persistently elevated despite adequate pharmacological therapy — exclude diabetes distress as a driver of poor adherence
• At diabetes diagnosis, initiation of insulin therapy, or other major treatment transitions
• When a patient expresses frustration, hopelessness, or burnout related to diabetes management
• Follow-up after initiating behavioral health or diabetes education interventions to assess response
• In patients with known depression to differentiate general depression from diabetes-specific distress

Formula

Pearls & pitfalls

• Diabetes distress is NOT the same as depression — a patient can score high on the DDS17 with a normal PHQ-9, and vice versa. Both should be screened independently.
• DDS Total ≥ 3.0 is the threshold for "high distress" requiring clinical action. A mean of 2.0–2.9 denotes moderate distress also warranting attention.
• The Regimen-Related Distress (RD) subscale is the most common driver of high total scores — address specific regimen barriers (complexity, hypoglycemia fear, monitoring burden).
• Physician-Related Distress (PD) is often under-recognized — a high PD subscale score may signal breakdown in therapeutic alliance that is preventing optimal care.
• Diabetes distress is particularly prevalent at HbA1c ≥ 8.0% — screen proactively in this group before attributing poor control solely to non-compliance.
• In type 1 diabetes, fear of hypoglycemia, technology burden (pumps, CGM), and the relentlessness of 24/7 disease management are common distress triggers addressed by the DDS.
• The DDS-2 (2-item screener using items 5 and 12) is available as a brief screening tool when the full DDS17 is impractical.
• ADA Standards of Care (2024) recommend routine psychosocial screening at diagnosis and thereafter at periodic intervals using a validated tool such as the DDS.

Next steps

Total DDS Mean < 2.0 (Little/No Distress): Reassure. Continue current management. Reassess annually or with major clinical changes. Total DDS Mean 2.0–2.9 (Moderate Distress): Clinical attention warranted. Explore specific subscale drivers. Consider referral to diabetes educator or behavioral health. Address patient-provider communication if PD subscale is elevated. Total DDS Mean ≥ 3.0 (High Distress): Significant distress requiring intervention. Offer diabetes-specific behavioral health support, peer support, or structured problem-solving. Review self-management barriers. High PD subscale (≥ 3.0): Review communication style and shared decision-making. High RD subscale (≥ 3.0): Simplify regimen, explore technology (CGM, AID systems), review patient education. High ID subscale (≥ 3.0): Family systems intervention or peer support groups.

Evidence

Polonsky WH et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28(3):626-631. PMID:15735199. Validated in 722 adults with type 2 diabetes. Confirmatory factor analysis in over 5,000 patients. Fisher L et al. When is diabetes distress clinically meaningful? Diabetes Care. 2012;35(2):259-264. — established 2.0 and 3.0 thresholds. DDS17 shows strong associations with HbA1c (r = 0.28–0.40), self-care behaviors, and quality of life. Cronbach alpha = 0.93 (total), 0.83–0.90 (subscales).

References

1. Polonsky WH et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28(3):626-631. — link
2. Fisher L et al. When is diabetes distress clinically meaningful? Establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012;35(2):259-264. — link
3. American Diabetes Association. Standards of Medical Care in Diabetes — 2024. Diabetes Care. 2024;47(Suppl 1). — link